Summary of Blood Pressure Goals and Initial Choice of Antihypertensive Agent for Patients With Diabetes Endorsed by Different Professional Societies or Expert Groups
| Recommendation (Year) | Blood Pressure Goals (mmHg) | First-Line Pharmacological Treatment |
|---|---|---|
| ADA (2018) | <140/90 (<130/80*) | ACEI/ARB†, thiazide-like diuretic, or dihydropyridine CCB |
| ACC/AHA (2017) | <130/80 | No preference |
| JNC 8 (2014) | <140/90 | Non-black: ACEI/ARB, thiazide-like diuretic, or CCB Black: thiazide-like diuretic or CCB |
| VA/DoD (2014) | <150/85 (140/85**) | Thiazide-like diuretic (chlorthalidone or indapamide) |
| CDA (2013) | <130/80 | ACEI/ARB‡, thiazide-like diuretic, or dihydropyridine CCB |
| ESH/ESC (2013) | <140/85 | ACEI/ARB†, thiazide-like diuretic, or CCB |
↵* May be appropriate for individuals at high risk of CVD.
↵** Suggested for patients who can tolerate the antihypertensive medications necessary to reach this goal.
↵† Recommended if hypertension is associated with proteinuria and suggested if hypertension is associated with microalbuminuria as the preferred first-line agent.
↵‡ Recommended in the presence of known kidney disease, including microalbuminuria, or CVD.